Jean Bennett: A Gene Therapy to Treat Blindness

03/05/18 • 12 min

Hear the story of the first gene therapy approved in the United States to target a disease caused by mutations in a specific gene. In this case, the RPE65 gene, which affects vision. For Dr. Jean Bennett, the physician scientist behind this medical breakthrough, being able to change the prognosis for people who are blind or losing their vision — and to see the profound impact that this has on their life — has been a career well spent.

Previous Episode

Amazing Things Podcast LIVE Congressional Briefing

A special live episode of UMR's Amazing Things Podcast broadcast from Capitol Hill in Washington D.C., on Wednesday, November 15, 2017. Host Adam Belmar is joined by four NIH-funded scientists: Dr. Ed Damiano of Boston University, Dr. Natalia Trayanova of Johns Hopkins University, Dr. Vadim Backman of Northwestern University and Dr. Li-Heui Tsai of Massachusetts Institute of Technology (MIT). The program includes remarks from U.S. Rep. Fred Upton of Michigan and U.S. Rep. Mike Simpson of Idaho.

Next Episode

Rep. Tom Cole: NIH Budget Has To Grow

Amazing Things Podcast: Newsmaker Edition.Oklahoma Congressman Tom Cole is a dedicated leader in the fight in Washington D.C. for sustained increases in federal funding for biomedical research through the National Institutes of Health. U.S. Rep. Cole, Chairman of the House Labor-HHS Appropriations Subcommittee, speaks candidly to Amazing Things about the promise of medical innovation, the scourge of disease and the critical importance of America's investment in biomedical research.